Editor's Choice–2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery …

V Aboyans, JB Ricco, MLEL Bartelink, M Björck… - European Journal of …, 2018 - ejves.com
Document Reviewers b, Petr Widimsky, Philippe Kolh, Stefan Agewall, Héctor Bueno,
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …

Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options

JW Olin, CJ White, EJ Armstrong… - Journal of the American …, 2016 - jacc.org
The prevalence of peripheral artery disease (PAD) continues to increase worldwide. It is
important to identify patients with PAD because of the increased risk of myocardial infarction …

[PDF][PDF] 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

V Aboyans, JB Ricco, ML Bartelink… - Kardiologia Polska …, 2017 - journals.viamedica.pl
W 2011 roku ESC opublikowało pierwsze wytyczne dotyczące rozpoznawania i leczenia
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …

[HTML][HTML] Editor's choice--European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral …

J Nordanstig, CA Behrendt, I Baumgartner… - European Journal of …, 2024 - Elsevier
BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions

DN Feldman, EJ Armstrong… - … : official journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions SCAI
consensus guidelines for device selection in femoral-popliteal arterial interventions Catheter …

Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis

D Koeckerling, PF Raguindin, L Kastrati… - European Heart …, 2023 - academic.oup.com
Aims Optimal endovascular management of intermittent claudication (IC) remains disputed.
This systematic review and meta-analysis compares efficacy and safety outcomes for …

[PDF][PDF] SCAI appropriate use criteria for peripheral arterial interventions: an update

AJ Klein, MR Jaff, BH Gray, HD Aronow, RM Bersin… - 2017 - deepblue.lib.umich.edu
In 2014, the Society for Cardiovascular Angiography and Interventions (SCAI) published the
first Appropriate Use Criteria (AUC) for endovascular therapy (EVT) for atherosclerotic …

Paclitaxel-eluting balloon versus standard balloon angioplasty in in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the …

CM Kinstner, J Lammer, A Willfort-Ehringer… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: The hypothesis that paclitaxel-eluting balloon angioplasty provides higher 1-
year patency rates in femoropopliteal artery in-stent restenosis compared with standard …

ACC/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison

AP Kithcart, JA Beckman - Journal of the American College of Cardiology, 2018 - jacc.org
Peripheral artery disease is a common yet underdiagnosed cause of morbidity worldwide.
Significant recent advances in management have resulted in new guideline creation for the …

[HTML][HTML] Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions

T Ohki, K Kichikawa, H Yokoi, M Uematsu… - Journal of Vascular …, 2017 - Elsevier
Objective The objective of this study was to assess 1-year safety, efficacy, and invasiveness
outcomes of endovascular stent grafting of symptomatic long lesions (≥ 10 cm) in the …